About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Boston | 459 Studies

Clinical Trials Prostate CancerBoston

Prostate Cancer Clinical Trials in Boston

Find 459 clinical trials for prostate cancer near Boston, Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 459 trials

CompletedAbiraterone Acetate for Castrate Resistant Prostate CancerThis research study is a Pilot clinical trial.NCT01961843·Boston, Massachusetts CompletedProspective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After SurgeryThe influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCRNCT02080689·Anchorage, Alaska and 18 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEarly Stage Prostate Cancer CohortEnvironmental factors such as diet and cigarette smoking may play a role in predicting the progression of early stage prostate cancer to advance disease.NCT00011349·Tucson, Arizona and 12 others

CompletedImproving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health InterventionThis study evaluates a smart phone based mobile application designed for patients with Renal Cell and Prostate Cancer taking oral anti-cancer medications.NCT02375776·Boston, Massachusetts

CompletedPhase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast CancerThe purpose of this first multi-dose study in cancer patients is to determine the maximum tolerated dose (MTD) or recommended phase II dose (RP2D), characterize the safety…NCT01338831·Boston, Massachusetts and 8 others

CompletedVideo Education With Result Dependent dIsclosureThe overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI)…NCT05225428·Boston, Massachusetts

CompletedStudy to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration resistant prostate cancer.NCT04428788·Stanford, California and 18 others

RecruitingA Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or DarolutamideThe purpose of this study is to find out whether talazoparib in combination with enzalutamide or talazoparib alone delays cancer progression in people with metastatic…NCT06844383·Duarte, California and 7 others

CompletedEribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyThis phase II trial is studying how well eribulin mesylate (E7389; Halichondrin B Analog) works in treating patients with metastatic prostate cancer that did not respond to…NCT00337077·Scottsdale, Arizona and 146 others

CompletedStudy Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPCThis research study is studying the safety and tolerability of an investigational combination of drugs, radium-223 plus pembrolizumab as a possible treatment for…NCT03093428·Boston, Massachusetts and 1 other

CompletedCyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionThe purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.NCT00643994·Phoenix, Arizona and 22 others

RecruitingThe Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death.NCT05926102·Boston, Massachusetts

RecruitingA Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesThis is a two-part, open-label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx)…NCT06395519·Phoenix, Arizona and 13 others

RecruitingReduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot FlashesThis is a prospective, randomized, non-pharmacologic interventional trial evaluating the effectiveness of the Embr Wave wearable thermal device in reducing hot flash burden in men…NCT07729150·Boston, Massachusetts

CompletedS9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate CancerRATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00004124·Anchorage, Alaska and 233 others

CompletedFractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate CancerThe objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to subjects and to determine the…NCT03737370·Boston, Massachusetts and 3 others

Active not recruitingA Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)This study will investigate the maximum tolerated dose, the recommended dose for expansion (RDE), safety, efficacy, and pharmacokinetics of gocatamig alone, gocatamig with…NCT04471727·Los Angeles, California and 10 others

Active not recruitingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.NCT01368588·Mobile, Alabama and 477 others

CompletedHormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00288080·Birmingham, Alabama and 253 others

RecruitingA Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.NCT06067841·Palo Alto, California and 14 others

PreviousPage 3 of 23Next

Other Conditions in Boston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma